Introduction
Historical Evolution of Hysteroscopy
Hysteroscopy was first performed on a patient in 1869 by Pantaleoni, who, using a cystoscope developed by Desormeaux, discovered and treated an endometrial polyp in a 60-year-old patient who presented with postmenopausal bleeding.[1] In the 20th century, hysteroscopy using distending media was developed, first using carbon dioxide in 1925. In-office hysteroscopy was introduced into clinical practice in the early 1980s with the improvement of distension media options and operative techniques.
Today, with the development of bipolar energy, various instruments, safe and effective distending media, optics, and smaller scope sizes, hysteroscopy is the preferred technique for managing intrauterine pathology. The utilization of in-office hysteroscopy depends not only on appropriate patient selection but also on the availability of equipment and resources. The preferred entry technique is vaginoscopy due to the reduction of intraprocedural and postprocedural pain. The efficacy of the vaginoscopic approach is comparable to the traditional entry approach.[2]
Hysteroscopy Overview
Hysteroscopy involves inserting a rigid or flexible hysteroscope through the cervical canal into the uterus and then using distending media to allow for complete visualization of the endometrial cavity. The type of distending media is selected based on the type of energy that will be used. Electrolyte-rich distention media may not be used if monopolar energy is used due to the risk of conducting electricity outside the operative field. Because of the potential for fluid overload and resulting complications, a fluid deficit with an upper limit of 1000 mL is recommended when using the hypotonic solution as the distending media.
A fluid deficit upper limit of 2500 mL is recommended when using the isotonic solution as the distending media. This limit does not apply to older adults or patients who have comorbidities. A fluid deficit cutoff of 750 mL for hypotonic solutions and 1500 mL for isotonic solutions is recommended in this population.[3] This is due to the potential for complications resulting from fluid overload. Normal saline has been found to provide better visualization and is associated with less postoperative pain than carbon dioxide.[4] Normal saline also allows for the utilization of bipolar electrocautery since it is isotonic.
The type of hysteroscope is selected based on operative needs. The 3 parts of the scope are the eyepiece, the barrel, and the objective lens. Scope viewing angles range from 0 to 70 degrees, with a decreased angle giving a more panoramic view. An operative hysteroscope is needed for surgical intervention. Options include a resectoscope, a hysteroscopic tissue retrieval system, or the addition of an operative sheath.[5]
With the invention of smaller hysteroscopes with reduced diameters and more technically advanced operating systems, in-office hysteroscopy has become a widely accepted method for diagnosing and treating intrauterine pathology. For women with abnormal uterine bleeding (AUB), hysteroscopy has been introduced as a viable or even superior alternative to hysterectomy in some cases.[6] Hysteroscopy has also been validated as a diagnostic tool for infertility workups.[7] Moreover, this procedure has been shown to be safe and effective for the removal of retained products of conception and foreign bodies.[8][9][10]
A new concept gaining popularity is the “see-and-treat” strategy, in which the patient is diagnosed during office hysteroscopy with an intrauterine organic pathology, eg, endometrial polyps or thickened endometrium. This identified pathology can then be treated hysteroscopically during the same visit. The see-and-treat strategy has all the same indications, and more, compared to traditional hysteroscopy, including thickened endometrium, endometrial pathology, retained products of conception, and retained foreign bodies. Polypectomy is the most common hysteroscopic procedure worldwide and can be easily transitioned to be performed through the see-and-treat method.[11][12]
Anatomy and Physiology
Register For Free And Read The Full Article
Search engine and full access to all medical articles
10 free questions in your specialty
Free CME/CE Activities
Free daily question in your email
Save favorite articles to your dashboard
Emails offering discounts
Learn more about a Subscription to StatPearls Point-of-Care
Anatomy and Physiology
The following anatomical structures are essential to understanding hysteroscopy and performing the proper technique:
- External genitalia: These anatomical structures are visible on inspection and do not require speculum examination. They include the mons pubis, clitoris, urethral meatus, vestibule of the vagina, labia majora and minora, vaginal opening, hymen, perineum, and anus. The external female genitalia is collectively known as the vulva.
- Vagina: The vagina is a muscular canal that connects the vulva to the cervix. This structure is an elastic passageway that varies in length and width and functions as a source of sexual pleasure and a route for fetal delivery. The vagina also conducts the passage of sperm after intercourse and blood during menses.
- Cervix: This structure is the opening from the vagina to the uterus, usually 2 or 3 cm in length. The cervix has a central opening called the cervical canal flanked by the external os anteriorly and the internal os posteriorly. Canal width varies throughout a female’s life, with maximal dilation to around 10 cm during childbirth.
- Uterus corpus: The uterus lies midline within the pelvis between the bladder anteriorly and the rectum posteriorly. It usually lies in an anteverted and anteflexed position. Version refers to the position of the cervix relative to the vagina, and flexion refers to the position of the fundus relative to the cervix. The fallopian tubes connect to the uterine corpus at the fundus bilaterally, with tubal ostia able to be visualized on hysteroscopy.
Indications
The most common indications for hysteroscopy are as follows:
- Suspicion of the intracavitary lesion
- Abnormal uterine bleeding
- Abnormal endometrial thickening
- Postmenopausal bleeding
- Infertility
- Mullerian congenital anomaly
- Removal of foreign bodies [13]
Whenever possible, in-office hysteroscopy is preferred. Compared to surgical inpatient hysteroscopy, in-office hysteroscopy offers many potential benefits, including patient and physician convenience, avoidance of general anesthesia, higher patient satisfaction, faster recovery, and cost-effectiveness.[14] Factors that challenge outpatient hysteroscopy feasibility include large intrauterine pathology, patient anxiety, lack of appropriate treatment setting and personnel, and physician skill and expertise.[15][14]
Contraindications
Hysteroscopy has few absolute contraindications, including active pelvic infection, prodromal or active genital herpes, and confirmed cervical or endometrial cancer. Moderate vaginal bleeding is a relative contraindication to hysteroscopy. However, adequate visualization for the procedure may be achieved with copious irrigation. Pregnancy is also a contraindication to hysteroscopy unless used in the setting of retained IUD or products of conception removal.
Medical comorbidities could be potential contraindications to hysteroscopic surgery (eg, coronary heart disease and bleeding diathesis).
Equipment
Hysteroscopes
Several types of hysteroscopes available for diagnostic and operative purposes deserve further explanation. The 2 main types of hysteroscopes are flexible and rigid. Hysteroscopes are available at viewing angles ranging from 0 to 70 degrees. They all easily connect to fluid channels, a light source, and a video monitoring system. A continuous flow of distending media is needed for optimal visualization of the endometrial cavity. Most hysteroscopes have an operative channel that permits the passage of surgical instruments such as small hysteroscopic graspers, scissors, or a tenaculum. The following hysteroscopes are among those commonly used:
- STORZ Bettocchi integrated in-office hysteroscope: this hysteroscope has a small diameter of 4mm (Bettocchi 4) or 5 mm (Bettocchi 5) with an oval tip that permits easy passage through the cervix, which is especially important when used in an office setting with conscious patients. It features 2.1 mm (Bettocchi 4) and 2.9 mm (Bettocchi 5) 12 and 30-degree optics and a working channel for 5 French semi-rigid operative instruments.
- STORZ Campo Trophyscope: This hysteroscope has an outer diameter of 2.9 mm, permitting even easier passage through the cervix due to the smaller scope diameter. However, with the Trophyscope, the intraoperative changeover to a continuous flow examination sheath is necessary. This sheath is 3.7 mm in diameter. It features a 30-degree scope with a working operative channel that allows for the introduction of 5 French semi-rigid instruments and bipolar electrodes.
- Olympus flexible hysteroscope: This hysteroscope has a flexible outer tip with a wide 100-degree tip angulation range that the operator may adjust. This scope is 3.1 mm in diameter. It features a wide field of view and an instrument channel.
Other types of rigid diagnostic and operative hysteroscopes range in diameter and degree of viewing angulation. In addition, the resectoscope and mini-resectoscope offer easy manipulation of electrocautery monopolar and bipolar loop devices that can be loaded into the scope, providing an easier dissection through dense tissue.[16]
Tissue Retrieval Systems
Several types of tissue retrieval systems on the market easily fragment and extract intrauterine pathology. These devices may be referred to as mechanical hysteroscopic tissue removal systems or mHTR systems. These systems overcome the limitations of traditional resectoscopic systems and methods because they do not use electrocautery to remove the pathology, thereby eliminating the risk of electrosurgical damage to surrounding structures and energetic reactions, including:
- Truclear 8.0 system: FDA approved in 2005, this mHTR is manufactured by Medtronic, is 9.0 mm in diameter, has a 0-degree optic device, a 4.0 mm disposable cutting device, and an operator to set window closure.
- TruClear elite: FDA approved in 2008, this mHTR is manufactured by Medtronic, is 7.25 mm in diameter, has a 0-degree optic device, 4.0 and 2.9 mm disposable cutting devices, and an operator to set window closure.
- Trueclear 5C system: FDA approved in 2012, this mHTR is manufactured by Medtronic, is 5.25 mm in diameter, has a 0-degree optic device, a 2.9 mm disposable cutting device, and an operator to set window closure.
- Integrated Bigatti shaver: FDA approved in 2012, this mHTR is manufactured by Storz, is 6.3 mm in diameter, has a 6-degree optic device, a 4.5 mm reusable cutting device, and automatic window closure.
- Myosure system: FDA approved in 2009, this mHTR is manufactured by Hologic, is 7.25 mm in diameter, has a 0-degree optic device, 3.0 and 4.0 mm disposable cutting devices, and automatic window closure.
- Synphioin system: FDA approved in 2014, this mHTR is manufactured by Boston Scientific and Minerva Surgical, is 6.3 mm in diameter, has a 0-degree optic device, a 3.6 mm disposable cutting device, and automatic window closure. Unique to this device is the capability for radiofrequency bipolar plasma tissue resection.
- Omni hysteroscope: FDA approved in 2018, this mHTR is 6.0 mm in diameter, has a 0-degree optic device, a 3.0 and 4.0 mm disposable cutting device, and automatic window closure.
Based on current literature, all mHTR systems demonstrate similar specifications and capabilities. These devices have been shown to be easy for surgeons to learn how to use and are associated with fewer complications than traditional resectoscopic approaches.[17]
Distension Medium
Adequate distention of the uterus is imperative to performing a hysteroscopy. Fluid or gas (carbon dioxide) may be used. However, carbon dioxide is only used during diagnostic hysteroscopies because visibility is lost with bleeding.[3] Fluid distension media allows the irrigation of the cavity for better visualization. With operative hysteroscopy and the electrical current loops used for dissection, fluid media must be carefully chosen. Fluid-containing electrolytes must not be utilized with monopolar current due to the risk of energy dispersal to surrounding tissues. When bipolar instruments are used, electrolyte-rich fluid-distending media, such as normal saline, may be selected.[18]
Other Instruments
The traditional hysteroscopic entry technique requires a tray with instruments for cervical dilation. These instruments and materials include a metal speculum, cervical tenaculum, sound, cervical dilators, ring forceps, and raytecs. Local anesthesia, if needed, might be selected based on operator preference. Preferred options include 1% or 2% lidocaine with or without epinephrine. A long 25- or 27-gauge needle is needed for the administration of anesthetic into the cervix.[19] With vaginoscopy and the no-touch technique, instruments apart from the hysteroscope are not required.[20]
Personnel
The number of personnel needed depends on where the hysteroscopy is undertaken. Personnel in the operating room include a dedicated anesthesiologist or certified nurse anesthetist, preoperative and postoperative care nurses and techs for operating room and supply maintenance, scrub techs, and transport staff.[21]
In the office, the number of staff needed is significantly reduced. Dedicated patient monitoring requires a staff member who is qualified to do so other than the physician. The presence of a team member with ACLS certification and capabilities is highly recommended. Another consideration for in-office hysteroscopy is equipment accessibility for treating cardiovascular emergencies and anaphylaxis. Dedicated anesthesia personnel are not needed in the office since the procedure is usually performed only with local or no anesthesia.[22]
Preparation
Preparation for hysteroscopy includes preoperative evaluation and individualized testing for patient needs. Further testing for preoperative clearance should be undertaken if comorbid conditions exist that increase operative morbidity. Hysteroscopy may be performed at any time in postmenopausal women. For premenopausal women, a consideration that performing a hysteroscopy during the secretory phase of the menstrual cycle may lead to an overdiagnosis of endometrial polyps is essential since the endometrium may appear polypoid during this time.[14] Using misoprostol for cervical dilation pre-procedure is not universally accepted and is not routinely performed.[23]
Prophylactic antibiotics are not needed for hysteroscopy.[24] A thorough history and physical should be conducted on every patient before a hysteroscopy is performed.[25] In addition, a preoperative pregnancy test should be performed on all premenopausal women. Currently, no consensus on pain management for in-office hysteroscopy has been established. Different protocols, both pharmacologic and nonpharmacologic, have been proposed.[26] Informed consent, including a discussion of risks, benefits, and alternatives, should always be obtained before any surgical procedure.[27][28][29]
Technique or Treatment
Hysteroscopy Set-Up
First, as with any gynecologic procedure, the appropriate positioning of the patient must be ensured. The patient is positioned in the dorsal lithotomy position, taking care to avoid unnecessary pressure that may cause nerve injury. The table must be flat; Trendelenberg positioning should be avoided. The bimanual examination should always be performed before the start of any gynecologic procedure. An indwelling Foley catheter is unnecessary; however, a straight catheter may drain the bladder before starting the procedure.
Next, the hysteroscope is set up, the camera is white-balanced and focused, and the inflow tract is primed. With the vaginoscopic entry technique, the need for the traditional instruments used for entry is avoided. The clinician begins vaginoscopy by introducing the hysteroscope into the vagina. The vagina is then distended, and the cervix and external os may be located by gently advancing the scope. The posterior fornix is usually easily identified. Once the external os is located, the hysteroscope is carefully inserted and passed through the internal os into the uterine cavity.
Insertion of the Hysteroscope and Uterine Cavity Assessment
Using standardized techniques, a speculum is first inserted. The cervix is visualized and grasped anteriorly with a single-tooth tenaculum. The cervix is then dilated to the diameter of the hysteroscope being used, after which the hysteroscope is inserted. At the same time, countertraction is applied with the tenaculum to straighten the uterus.
Once inside the uterus, the entire uterine cavity may be inspected. Any pathology can be quickly identified, and preoperative planning can be performed. The bilateral tubal ostia should be identified at the beginning of the case.
Hysteroscopic Procedures
Further technique varies depending on the type of intrauterine pathology. Operative techniques as they apply to fibroids, polyps, adhesions, and retained intrauterine devices will be reviewed here. AUB is the most common indication for hysteroscopy with structural abnormalities such as polyps or fibroids, usually as root causes.[30]
Hysteroscopic myomectomy
Hysteroscopic myomectomy can be performed in numerous ways. Submucosa myomas are accessible by operative hysteroscopy and are divided into types 0, I, and II based on their distribution within the myometrium. Type 0 is fully intracavitary, type I is mostly intracavitary, and type II is mostly myometrial. Since type 0 fibroids are usually pedunculated, they may be resected easily depending on their size, using sharp dissection, electrocautery, or a loop dissection device.[31] Type I and Type II myoma resection often requires 2 surgical procedures to achieve full resection. The excision of only the intracavitary portion of a fibroid is not recommended due to its propensity for intracavitary regrowth. Resectoscopic progressive excision followed by interval complete excision after the fibroid spontaneously migrates into the cavity has been shown to be a successful strategy.[5] Some studies show higher success rates for total removal of intrauterine pathology with these systems, with no significant difference in complication rates. However, the tissue removal system group reported a higher fluid deficit.[30]
Pretreatment with GnRH agonists to shrink fibroids and correct anemia is not universally performed. Small studies have shown the benefits of GnRH agonist use for submucosal fibroids greater than 3 cm for a period ranging from 6 weeks to 4 months. However, this drug class causes unpleasant adverse effects, including hot flashes, decreased libido, and insomnia. One recent retrospective study found that treatment before surgery was associated with longer surgical times and increased cervical resistance. Consider shared decision-making and patient individualization before prescribing medical pretreatment.[5]
Hysteroscopic polypectomy
Hysteroscopic polypectomy can be carried out with operative microscissors or monopolar or bipolar electrocautery. Nonhysteroscopic polypectomy, eg, with polyp forceps, has a higher recurrence rate than hysteroscopic polypectomy.[32] With mechanical tissue removal systems, data show increased rates of complete pathology resection and shorter operation times for the resectioning of polyps.[30]
Hysteroscopic resection
With hysteroscopy, the removal of a uterine septum, or, in other words, the performance of a uterine septoplasty, has become possible. Likewise, the resection of intrauterine adhesions spurred by a history of endometrial trauma is termed hysteroscopic adhesiolysis. These 2 abnormalities are associated with infertility and can be remedied with resection as long as they do not reform. A Cochrane review published in 2017 suggests limited evidence for medical or IUD treatment in operative hysteroscopy to prevent intrauterine adhesion formation.[33]
Hysteroscopic retrieval
Hysteroscopy is a safe and effective method for the retrieval of retained or embedded devices, the most common of which are intrauterine devices (IUDs). Hysteroscopy may even be used in the first trimester of pregnancy to retrieve IUDs when strings cannot be seen on the pelvic exam. Pregnancies with retained IUDs are associated with increased rates of miscarriage, preterm delivery, and chorioamnionitis. Hysteroscopic removal for a retained IUD is an emerging option for treatment, especially when ultrasound-guided removal is not feasible.[34][35]
Postoperative Management
Most patients tolerate diagnostic and operative hysteroscopy well and can be discharged from the postoperative recovery unit or office setting soon after the completion of the procedure. Vaginal spotting and discomfort are common. Recommendations for the timing of pelvic rest vary by clinician, with some saying that normal activities may resume in 24 hours, especially when the vaginoscopy “no-touch” entry technique is used. A follow-up appointment should be arranged before discharge for an anticipatory review of pathology results.
Complications
Overall, hysteroscopy is regarded as a safe, minimally invasive procedure.[36] However, the procedure is associated with several complications that clinicians should learn to recognize and manage promptly.
Uterine Perforation
The most common reported complication of both diagnostic and operative hysteroscopy is uterine perforation.[37] Perforation can occur at any point during the procedure but is more common with resection extending into the uterine myometrium.[38] Encountered in about 1% of cases, uterine perforation may be managed conservatively or operatively, depending on patient status. Hemodynamic status should first be assessed with low suspicion for vascular injury if perforation was caused by blunt dissection. If the patient is hemodynamically stable and there is low suspicion of vascular or visceral damage, laparoscopy or exploratory laparotomy is unneeded. Prolonged postoperative same-day recovery is recommended with strict pain, bleeding, and fever precautions and close clinical follow-up.[39]
Bleeding alone without uterine perforation may be encountered with deep dissection into the myometrium and intersection with a perforating vessel. This complication is more common with operative hysteroscopy and the removal of type I and type II subserosal fibroids. Bleeding may be managed with electrocautery, uterotonics such as oxytocin, or foley balloon catheter placement to be left inside the uterus to tamponade bleeding.[39]
Fluid Overload
Complications associated with distension media used in hysteroscopy deserve detailed discussion. The fluid deficit is carefully calculated intraoperatively to quantify the amount of fluid the patient is absorbing into their circulation. Of particular concern is the risk of hyponatremia and resulting cerebral edema, especially when electrolyte-free hypotonic solutions are used. Cerebral edema may manifest with symptoms of nausea and or vomiting, dizziness, shortness of breath, or headache. The mechanism of fluid absorption has to do with the amount of intrauterine pressure created by hysteroscopic fluid management systems and the venous absorption of distending media.[36] Some institutions recognize this as operative hysteroscopy intravascular absorption syndrome (OHIA).
Electrolyte-rich isotonic fluid, eg, normal saline, may be used with bipolar systems. As such, bipolar systems have less risk of fluid overload syndromes. In healthy women, hysteroscopy should be aborted if the fluid deficit exceeds 2500 mL when isotonic distention media is used and 1000 mL with hypotonic media. In women with comorbidities (eg, cardiac or pulmonary conditions) that compromise hemodynamic stability, the surgeon should consider termination of the procedure with a fluid deficit of 1000 mL and 750 mL of an isotonic and hypotonic solution, respectively. Avoidance of OHIA can be achieved by closely monitoring fluid status. Patients at risk for OHIA may be identified beforehand by assessing estimated procedure time, risk for incomplete resection of intrauterine pathology, and the existence of comorbidities.
Air Embolism
Hysteroscopy can result in carbon dioxide embolism if used as the distending media. This complication can be catastrophic if it occurs due to the potential for cardiac failure, leading to death. Limited studies show a wide-ranging air embolism rate from 10% to 50% with the use of carbon dioxide.[40] If this complication is suspected, the anesthesia team should immediately advise the surgeon, and the procedure should be terminated. Durant’s position (ie, patient placement in left lateral decubitus and Trendelenberg) may assist in air migration away from the right ventricular outflow tract. If cardiac arrest occurs, cardiac catheterization may be performed to relieve the embolized air from the cardiovascular system. This iatrogenic complication of hysteroscopy may be prevented by using fluid-distending media and priming equipment by releasing air from tubing and avoiding excessive instrumentation, which may introduce air into the genital tract.
Vasovagal Syncope
While the risk of a vasovagal syncope reaction is low, ranging from 0.21% to 1.85% of patients undergoing in-office hysteroscopy, this is an unpleasant adverse effect to undergo as the patient or treat as the clinician. Sometimes overlooked because of its short-lived and benign nature, vasovagal syncope occurs with exposure to pain, emotional stress, or in medical settings. Most patients develop an “aura” before either fully or partially experiencing syncope, with this "aura" consisting of some combination of lightheadedness, paleness, palpitations, sweating, and blurred vision.
Risk factors for vasovagal syncope include young age, female gender, low body mass index, Caucasian race, and family history. If this complication occurs during an in-office hysteroscopy, the procedure should be halted for appropriate patient evaluation. This evaluation should assess the ABCs (airway, breathing, and circulation). For treatment, the patient may be placed in the Trendelenburg position and the intrauterine pressure decreased by closing the inflow or removing the hysteroscopic device. If bradycardia, hypotension, or patient symptoms persist, the patient should be referred to the emergency department for further evaluation and observation.[41]
Clinical Significance
The gold standard for the diagnosis and treatment of intrauterine pathology is hysteroscopy. As such, this technique has numerous indications and benefits. Hysteroscopy can improve quality of life, treat infertility, remove foreign bodies, or diagnose malignancy. Women with abnormal uterine bleeding may experience significant improvement in symptoms post hysteroscopic resection of pathology, avoiding the need for invasive surgical procedures such as hysterectomy.[42]
Also, compared to blind endometrial sampling, direct visualization of the entire uterine cavity and biopsy with hysteroscopy allows for targeted sampling and complete resection of uterine abnormalities such as polyps. These have the potential for malignancy, especially in postmenopausal women and women with a family history of gynecologic cancer. Further, ambulatory hysteroscopy offers appeal with the potential avoidance of general anesthesia or conscious sedation. Studies comparing in-office to operating room hysteroscopy show comparable patient acceptance and outcomes, as well as decreased cost.[43]
Enhancing Healthcare Team Outcomes
If a hysteroscopy is performed in the ambulatory or inpatient operating room setting, more personnel must be included in the interprofessional healthcare team. Technicians and representatives should confirm that all equipment functions properly before the patient enters the operating room. Scrub technicians are essential in prepreparing equipment so delays and malfunctions may be limited. The final patient assessment before surgery should always be prompted by the circulator or other operating room staff and include a pelvic examination.
Effective communication is paramount at every stage, beginning with team briefings and culminating in a formal time-out to confirm procedural details. Anesthesia should direct patient positioning to avoid dislodging endotracheal tubes, lines, and other monitoring systems. Throughout the procedure, appropriate attention to surgical undertakings is needed from the scrub tech and circulator to maintain adequate lighting, fluid balance, and distending media pressure. Equipment adjustments, such as those for display monitors or electrocautery instruments, may also be needed.
At the procedure's end, all fluids in, fluids out, blood loss, and urine output are documented and announced by the circulator nurse. Anesthesia must continue to monitor hemodynamic and respiratory statuses after extubation or weaning from sedation. However, it is essential to remember that all healthcare team members are responsible for working together to ensure the patient's safety. Seamless communication and collaboration across all stages of hysteroscopy—preoperative, intraoperative, and postoperative—enhance patient-centered care and team efficiency. Nursing staff must remain well-informed about patient status to ensure a cohesive and safe surgical experience.
In-office hysteroscopy does not need to consist of more than 2 to 3 personnel. The surgeon may be semi-self-sufficient, and a scrub tech is not required. However, the clinician must understand and review the equipment thoroughly. In academic centers, in-office hysteroscopy offers more involvement for residents and medical students, as personnel is reduced, but assistance may be needed to ensure smooth operation in the awake patient. Patient comfort and assurance are of utmost importance. The right demeanor in an in-office hysteroscopy team can ease anxiety and improve outcomes.
References
Marlow JL. Media and delivery systems. Obstetrics and gynecology clinics of North America. 1995 Sep:22(3):409-22 [PubMed PMID: 8524528]
Chapa HO, Venegas G. Vaginoscopy compared to traditional hysteroscopy for hysteroscopic sterilization. A randomized trial. The Journal of reproductive medicine. 2015 Jan-Feb:60(1-2):43-7 [PubMed PMID: 25745750]
Level 1 (high-level) evidenceUmranikar S, Clark TJ, Saridogan E, Miligkos D, Arambage K, Torbe E, Campo R, Di Spiezio Sardo A, Tanos V, Grimbizis G, British Society for Gynaecological Endoscopy /European Society for Gynaecological Endoscopy Guideline Development Group for Management of Fluid Distension Media in Operative Hysteroscopy. BSGE/ESGE guideline on management of fluid distension media in operative hysteroscopy. Gynecological surgery. 2016:13(4):289-303. doi: 10.1007/s10397-016-0983-z. Epub 2016 Oct 6 [PubMed PMID: 28003797]
Level 2 (mid-level) evidencePellicano M, Guida M, Zullo F, Lavitola G, Cirillo D, Nappi C. Carbon dioxide versus normal saline as a uterine distension medium for diagnostic vaginoscopic hysteroscopy in infertile patients: a prospective, randomized, multicenter study. Fertility and sterility. 2003 Feb:79(2):418-21 [PubMed PMID: 12568856]
Level 1 (high-level) evidenceDi Spiezio Sardo A, Mazzon I, Bramante S, Bettocchi S, Bifulco G, Guida M, Nappi C. Hysteroscopic myomectomy: a comprehensive review of surgical techniques. Human reproduction update. 2008 Mar-Apr:14(2):101-19 [PubMed PMID: 18063608]
Tarneja P, Duggal BS. Hysteroscopy: Past, Present and Future. Medical journal, Armed Forces India. 2002 Oct:58(4):293-4. doi: 10.1016/S0377-1237(02)80079-X. Epub 2011 Jul 21 [PubMed PMID: 27407415]
Pansky M, Feingold M, Sagi R, Herman A, Schneider D, Halperin R. Diagnostic hysteroscopy as a primary tool in a basic infertility workup. JSLS : Journal of the Society of Laparoendoscopic Surgeons. 2006 Apr-Jun:10(2):231-5 [PubMed PMID: 16882426]
Level 2 (mid-level) evidenceAlonso Pacheco L, Timmons D, Saad Naguib M, Carugno J. Hysteroscopic management of retained products of conception: A single center observational study. Facts, views & vision in ObGyn. 2019 Sep:11(3):217-222 [PubMed PMID: 32082527]
Level 2 (mid-level) evidenceXia E, Duan H, Huang X, Zheng J, Yu D, Cheng L. Hysteroscopic removal of foreign bodies and its method of monitoring. Chinese medical journal. 2003 Jan:116(1):125-8 [PubMed PMID: 12667404]
Carugno J, Grimbizis G, Franchini M, Alonso L, Bradley L, Campo R, Catena U, Carlo A, Attilio DSS, Martin F, Haimovich S, Isaacson K, Moawad N, Saridogan E, Clark TJ. International Consensus Statement for Recommended Terminology Describing Hysteroscopic Procedures. Journal of minimally invasive gynecology. 2022 Mar:29(3):385-391. doi: 10.1016/j.jmig.2021.10.004. Epub 2021 Oct 12 [PubMed PMID: 34648932]
Level 3 (low-level) evidenceRaz N, Sigal E, Gonzalez Arjona F, Calidona C, Garzon S, Uccella S, Laganà AS, Haimovich S. See-and-treat in-office hysteroscopy versus operative hysteroscopy for the treatment of retained products of conception: A retrospective study. The journal of obstetrics and gynaecology research. 2022 Sep:48(9):2459-2465. doi: 10.1111/jog.15327. Epub 2022 Jun 13 [PubMed PMID: 35698805]
Level 2 (mid-level) evidenceGupta JK, Clark TJ, More S, Pattison H. Patient anxiety and experiences associated with an outpatient "one-stop" "see and treat" hysteroscopy clinic. Surgical endoscopy. 2004 Jul:18(7):1099-104 [PubMed PMID: 15136927]
Yen CF, Chou HH, Wu HM, Lee CL, Chang TC. Effectiveness and appropriateness in the application of office hysteroscopy. Journal of the Formosan Medical Association = Taiwan yi zhi. 2019 Nov:118(11):1480-1487. doi: 10.1016/j.jfma.2018.12.012. Epub 2019 Jan 2 [PubMed PMID: 30611636]
. The Use of Hysteroscopy for the Diagnosis and Treatment of Intrauterine Pathology: ACOG Committee Opinion, Number 800. Obstetrics and gynecology. 2020 Mar:135(3):e138-e148. doi: 10.1097/AOG.0000000000003712. Epub [PubMed PMID: 32080054]
Level 3 (low-level) evidenceGambadauro P, Navaratnarajah R, Carli V. Anxiety at outpatient hysteroscopy. Gynecological surgery. 2015:12(3):189-196 [PubMed PMID: 26283891]
Level 2 (mid-level) evidenceRoy KK, Lingampally A, Kansal Y, Bharti J, Kumar S, Vanamail P, Singhal S, Meena J. A Pilot Study Comparing Hysteroscopic Adhesiolysis by Conventional Resectoscope Versus Mini-resectoscope. Oman medical journal. 2017 Nov:32(6):492-498. doi: 10.5001/omj.2017.94. Epub [PubMed PMID: 29218126]
Level 3 (low-level) evidenceVitale SG, Giannini A, Carugno J, van Herendael B, Riemma G, Pacheco LA, Drizi A, Mereu L, Bettocchi S, Angioni S, Haimovich S. Hysteroscopy: where did we start, and where are we now? The compelling story of what many considered the "Cinderella" of gynecological endoscopy. Archives of gynecology and obstetrics. 2024 Oct:310(4):1877-1888. doi: 10.1007/s00404-024-07677-x. Epub 2024 Aug 16 [PubMed PMID: 39150502]
Level 2 (mid-level) evidenceAbdallah KS, Gadalla MA, Breijer M, Mol BWJ. Uterine distension media for outpatient hysteroscopy. The Cochrane database of systematic reviews. 2021 Nov 26:11(11):CD006604. doi: 10.1002/14651858.CD006604.pub2. Epub 2021 Nov 26 [PubMed PMID: 34826139]
Level 1 (high-level) evidence. ACOG Technology Assessment No. 13: Hysteroscopy. Obstetrics and gynecology. 2018 May:131(5):1. doi: 10.1097/AOG.0000000000002634. Epub [PubMed PMID: 29683912]
Sharma M, Taylor A, di Spiezio Sardo A, Buck L, Mastrogamvrakis G, Kosmas I, Tsirkas P, Magos A. Outpatient hysteroscopy: traditional versus the 'no-touch' technique. BJOG : an international journal of obstetrics and gynaecology. 2005 Jul:112(7):963-7 [PubMed PMID: 15958000]
Level 1 (high-level) evidenceWeinbroum AA, Ekstein P, Ezri T. Efficiency of the operating room suite. American journal of surgery. 2003 Mar:185(3):244-50 [PubMed PMID: 12620564]
Moawad NS, Santamaria E, Johnson M, Shuster J. Cost-effectiveness of office hysteroscopy for abnormal uterine bleeding. JSLS : Journal of the Society of Laparoendoscopic Surgeons. 2014 Jul-Sep:18(3):. doi: 10.4293/JSLS.2014.00393. Epub [PubMed PMID: 25392645]
Hua Y, Zhang W, Hu X, Yang A, Zhu X. The use of misoprostol for cervical priming prior to hysteroscopy: a systematic review and analysis. Drug design, development and therapy. 2016:10():2789-2801 [PubMed PMID: 27660411]
Level 1 (high-level) evidence. ACOG Practice Bulletin No. 195: Prevention of Infection After Gynecologic Procedures. Obstetrics and gynecology. 2018 Jun:131(6):e172-e189. doi: 10.1097/AOG.0000000000002670. Epub [PubMed PMID: 29794678]
Shields J, Lupo A, Walsh T, Kho K. Preoperative evaluation for gynecologic surgery: a guide to judicious, evidence-based testing. Current opinion in obstetrics & gynecology. 2018 Aug:30(4):252-259. doi: 10.1097/GCO.0000000000000472. Epub [PubMed PMID: 29889669]
Level 3 (low-level) evidenceVitale SG, Alonso Pacheco L, Haimovich S, Riemma G, De Angelis MC, Carugno J, Lasmar RB, Di Spiezio Sardo A. Pain management for in-office hysteroscopy. A practical decalogue for the operator. Journal of gynecology obstetrics and human reproduction. 2021 Jan:50(1):101976. doi: 10.1016/j.jogoh.2020.101976. Epub 2020 Nov 6 [PubMed PMID: 33166706]
Hanson M, Pitt D. Informed consent for surgery: risk discussion and documentation. Canadian journal of surgery. Journal canadien de chirurgie. 2017 Feb:60(1):69-70 [PubMed PMID: 28234594]
Salazar CA, Isaacson KB. Office Operative Hysteroscopy: An Update. Journal of minimally invasive gynecology. 2018 Feb:25(2):199-208. doi: 10.1016/j.jmig.2017.08.009. Epub 2017 Aug 10 [PubMed PMID: 28803811]
Ahmad G, Saluja S, O'Flynn H, Sorrentino A, Leach D, Watson A. Pain relief for outpatient hysteroscopy. The Cochrane database of systematic reviews. 2017 Oct 5:(10)(10):CD007710. doi: 10.1002/14651858.CD007710.pub3. Epub 2017 Oct 5 [PubMed PMID: 35611933]
Level 1 (high-level) evidenceYin X, Cheng J, Ansari SH, Campo R, Di W, Li W, Bigatti G. Hysteroscopic tissue removal systems for the treatment of intrauterine pathology: a systematic review and meta-analysis. Facts, views & vision in ObGyn. 2018 Dec:10(4):207-213 [PubMed PMID: 31367293]
Level 1 (high-level) evidencePiecak K, Milart P. Hysteroscopic myomectomy. Przeglad menopauzalny = Menopause review. 2017 Dec:16(4):126-128. doi: 10.5114/pm.2017.72757. Epub 2017 Dec 30 [PubMed PMID: 29483854]
Preutthipan S, Herabutya Y. Hysteroscopic polypectomy in 240 premenopausal and postmenopausal women. Fertility and sterility. 2005 Mar:83(3):705-9 [PubMed PMID: 15749501]
Level 2 (mid-level) evidenceBosteels J, Weyers S, D'Hooghe TM, Torrance H, Broekmans FJ, Chua SJ, Mol BWJ. Anti-adhesion therapy following operative hysteroscopy for treatment of female subfertility. The Cochrane database of systematic reviews. 2017 Nov 27:11(11):CD011110. doi: 10.1002/14651858.CD011110.pub3. Epub 2017 Nov 27 [PubMed PMID: 29178172]
Level 1 (high-level) evidenceSanders AP, Fluker MR, Sanders BH. Saline Hysteroscopy for Removal of Retained Intrauterine Contraceptive Devices in Early Pregnancy. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC. 2016 Dec:38(12):1114-1119. doi: 10.1016/j.jogc.2016.08.013. Epub 2016 Sep 29 [PubMed PMID: 27986186]
Pollak VE. Adverse effects and pyrogenic reactions during hemodialysis. JAMA. 1988 Oct 14:260(14):2106-7 [PubMed PMID: 3418877]
Aas-Eng MK, Langebrekke A, Hudelist G. Complications in operative hysteroscopy - is prevention possible? Acta obstetricia et gynecologica Scandinavica. 2017 Dec:96(12):1399-1403. doi: 10.1111/aogs.13209. Epub 2017 Sep 27 [PubMed PMID: 28832907]
Aydeniz B, Gruber IV, Schauf B, Kurek R, Meyer A, Wallwiener D. A multicenter survey of complications associated with 21,676 operative hysteroscopies. European journal of obstetrics, gynecology, and reproductive biology. 2002 Sep 10:104(2):160-4 [PubMed PMID: 12206931]
Level 3 (low-level) evidenceAgostini A, Cravello L, Bretelle F, Shojai R, Roger V, Blanc B. Risk of uterine perforation during hysteroscopic surgery. The Journal of the American Association of Gynecologic Laparoscopists. 2002 Aug:9(3):264-7 [PubMed PMID: 12101319]
Level 2 (mid-level) evidenceIstre O. Managing bleeding, fluid absorption and uterine perforation at hysteroscopy. Best practice & research. Clinical obstetrics & gynaecology. 2009 Oct:23(5):619-29. doi: 10.1016/j.bpobgyn.2009.03.003. Epub 2009 Apr 16 [PubMed PMID: 19375391]
Verma A, Singh MP. Venous gas embolism in operative hysteroscopy: A devastating complication in a relatively simple surgery. Journal of anaesthesiology, clinical pharmacology. 2018 Jan-Mar:34(1):103-106. doi: 10.4103/joacp.JOACP_235_15. Epub [PubMed PMID: 29643632]
Rodriguez S, Haimovich S, Vitale SG, Alonso L, Carugno J. Vasovagal Syncope during Office Hysteroscopy-A Frequently Overlooked Unpleasant Complication. Medicina (Kaunas, Lithuania). 2022 Nov 11:58(11):. doi: 10.3390/medicina58111626. Epub 2022 Nov 11 [PubMed PMID: 36422165]
Brill AI. What is the role of hysteroscopy in the management of abnormal uterine bleeding? Clinical obstetrics and gynecology. 1995 Jun:38(2):319-45 [PubMed PMID: 7554600]
Bakour SH, Jones SE, O'Donovan P. Ambulatory hysteroscopy: evidence-based guide to diagnosis and therapy. Best practice & research. Clinical obstetrics & gynaecology. 2006 Dec:20(6):953-75 [PubMed PMID: 17116420]